The trial expansion was granted after RevBio demonstrated the safety of Tetranite in the first five treated patients.

Furthermore, traditional cranial flap closure methods do not lead to the full osseous reintegration of the flap with the skull, resulting in issues with flap movement, patient pain, and the ...